The Food and Drugs Board (FDB) is warning the general public about the circulation of some counterfeit anti-malarial medicines in the Ashanti Region. According to a statement issued by the FDB's Chief Executive, Dr. Stephen K. Opuni, the counterfeit anti-malarial medicines, when used could lead to further complications of the disease condition and possible death. These counterfeit anti-malarial medicines were sampled through the FDB/USP-PQM Post-Market Surveillance activities, the statement said.
Below are the names of the counterfeit anti-malarial medicines with their respective batch numbers, the Pharmacies and Chemical Shops where the counterfeit anti-malarial medicines were stocked.
Additionally, it noted that the Akoma Pharmaceutical Limited, the manufacturer of the Quinine Syrup is not registered by the Food and Drugs Board to manufacture and distribute pharmaceutical products.
“The general public is therefore being warned to be careful when purchasing medicines from the above-mentioned facilities.”Meanwhile, the FDB said it is taking the necessary regulatory actions against the unlicensed manufacturer, importers, distributors and retailers of these medicines.
The statement also advised any wholesaler, pharmacy or licensed chemical shop that has in stock these counterfeit anti-malarial medicines (with the specified batch numbers) should immediately return them to the nearest Food and Drugs Board.